We are live on ! Find out more
FMTX

Forma Therapeutics Holdings, Inc. Common Stock

Delisted

FMTX was delisted on the 13th of October, 2022.

139 hedge funds and large institutions have $835M invested in Forma Therapeutics Holdings, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 58 funds opening new positions, 37 increasing their positions, 29 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

228% more capital invested

Capital invested by funds: $255M → $835M (+$580M)

142% more first-time investments, than exits

New positions opened: 58 | Existing positions closed: 24

100% more funds holding in top 10

Funds holding in top 10: 24 (+2)

78% more call options, than puts

Call options by funds: $20.1M | Put options by funds: $11.3M

32% more funds holding

Funds holding: 105139 (+34)

28% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 29

Holders
139
Holders Change
+34
Holders Change %
+32.38%
% of All Funds
2.39%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.07%
New
58
Increased
37
Reduced
29
Closed
24
Calls
$20.1M
Puts
$11.3M
Net Calls
+$8.84M
Net Calls Change
+$9.38M
Name Holding Trade Value Shares
Change
Change in
Stake
AA
26
AQR Arbitrage
Connecticut
$6.57M +$4.34M +329,444 New
Goldman Sachs
27
Goldman Sachs
New York
$6.42M +$1.78M +135,211 +73%
GLAM
28
Gardner Lewis Asset Management
Pennsylvania
$6.38M +$4.22M +320,000 New
E
29
Ergoteles
New York
$5.98M +$2.76M +208,984 +231%
Bank of America
30
Bank of America
North Carolina
$5.8M +$2.37M +179,506 +162%
Wellington Management Group
31
Wellington Management Group
Massachusetts
$5.59M +$2.52M +191,002 +214%
Charles Schwab
32
Charles Schwab
California
$5.47M +$464K +35,146 +15%
EFI
33
EHP Funds Inc
Canada
$4.99M +$3.3M +250,000 New
KC
34
Kryger Capital
United Kingdom
$4.85M +$3.21M +243,303 New
Dimensional Fund Advisors
35
Dimensional Fund Advisors
Texas
$4.79M +$1.95M +147,946 +161%
GF
36
Gabelli Funds
New York
$4.66M +$3.08M +233,414 New
UBS Group
37
UBS Group
Switzerland
$4.44M +$2.37M +179,496 +415%
MF
38
Magnetar Financial
Illinois
$4.4M +$2.91M +220,726 New
Qube Research & Technologies (QRT)
39
Qube Research & Technologies (QRT)
United Kingdom
$4.02M +$2.19M +166,372 +472%
N
40
Nuveen
North Carolina
$4.01M -$177K -13,458 -6%
MS
41
Maven Securities
Jersey
$3.99M +$2.64M +200,000 New
MAM
42
Miria Asset Management
Malta
$3.49M +$2.31M +174,900 New
PCM
43
Prelude Capital Management
New York
$3.42M +$2.26M +171,295 New
IHAM
44
Integral Health Asset Management
New York
$3.31M -$502K -38,051 -29%
YCM
45
Yakira Capital Management
Connecticut
$3.29M +$2.17M +164,805 New
KCM
46
Kennedy Capital Management
Missouri
$3.06M +$1.09M +82,793 +117%
BC
47
Brookfield Corp
Ontario, Canada
$2.99M +$1.98M +150,100 New
DAM
48
DLD Asset Management
New York
$2.99M +$1.98M +150,000 New
GCIA
49
Gabelli & Co Investment Advisers
New York
$2.96M +$1.96M +148,550 New
Prudential Financial
50
Prudential Financial
New Jersey
$2.9M +$505K +38,300 +36%

FMTX Hedge Fund Activity: Q3 2022 in Review

139 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Forma Therapeutics Holdings, Inc. Common Stock (FMTX) for Q3 2022, worth a combined $835M — up 228% from $255M a quarter earlier.

Buyers outnumbered sellers: 58 funds opened new FMTX positions and 24 closed out — a net gain of 34 holders — while 37 added to existing stakes and 29 trimmed.

The largest buyer was TIG Advisors LLC, opening a new position worth an estimated $17.2M. The largest seller was Deep Track Capital, cutting an estimated $40.7M.

  • 139 institutional investors held Forma Therapeutics Holdings, Inc. Common Stock (FMTX) as of Q3 2022, up from 105 in Q2 2022.
  • Funds reported $835M of Forma Therapeutics Holdings, Inc. Common Stock stock for Q3 2022, up 228% quarter-over-quarter.
  • 58 funds opened new Forma Therapeutics Holdings, Inc. Common Stock positions in Q3 2022 and 24 closed out, a net change of +34 holders.
  • The largest Forma Therapeutics Holdings, Inc. Common Stock buyer in Q3 2022 was TIG Advisors LLC, an estimated $17.2M added.
  • The largest Forma Therapeutics Holdings, Inc. Common Stock seller in Q3 2022 was Deep Track Capital, an estimated $40.7M sold.

Based on aggregated 13F filings for Q3 2022.